Searchable abstracts of presentations at key conferences in endocrinology

ea0090p424 | Pituitary and Neuroendocrinology | ECE2023

The acro-TIME score: a new clinical, pathological and immune integrative approach to early identify acromegaly patients resistant to treatment with first generation somatostatin ligands

Chiloiro Sabrina , Giampietro Antonella , Gessi Marco , Lauretti Liverana , Mattogno Pierpaolo , Costanza Flavia , Carlino Angela , Olivi Alessandro , Rindi Guido , Pontecorvi Alfredo , De Marinis Laura , Doglietto Francesco , Bianchi Antonio

Somatotropinomas are benign pituitary tumors, with a heterogenous biological and clinical behavior. Tumor microenvironment reflects the interaction between tumor cells and the host immune system and may regulate tumor behavior and therapy outcome. We develop a scoring system that includes clinical, pathological and immune markers to early identify fg-SRLs resistant acromegaly pts. 43 acromegaly pts were included according the following criteria (1) first line treatment with su...

ea0090p438 | Pituitary and Neuroendocrinology | ECE2023

The Role of the GH Receptor Polymorphism as Prognostic Factor of Vertebral Fractures in Acromegaly Patients Resistant to First Generation SSAs and Treated with GH Receptor Antagonist or Second-Generation Somatostatin Ligand

Costanza Flavia , Chiloiro Sabrina , Giampietro Antonella , Mattogno Pierpaolo , Amato Infante , Angelini Flavia , Lauretti Liverana , Olivi Alessandro , Pontecorvi Alfredo , Doglietto Francesco , De Marinis Laura , Bianchi Antonio

Acromegaly is associated with skeletal fragility and an increased prevalence of vertebral fractures (VF). In recent years several authors have tried to investigate the markers that can predict the risk of bone fragility in this endocrine disorder. Two different isoforms of the GH receptor (GHR) have been described so far, which differ in the presence or absence of a transcript of exon 3 of the GHR gene. Both isoforms produce a functional receptor, but the exon 3-deleted isofor...

ea0090ep628 | Endocrine-related Cancer | ECE2023

Pancreas, An Unusual Metastatic Site In A Long-term Indolent Surviving Case, Under Somatostatin Analogues Therapy, Of Medullary Thyroid Carcinoma: A Case Report And Review Of Cases Documented In Literature

Raia Salvatore , Chiloiro Sabrina , Giampietro Antonella , Grazia Maratta Maria , Schinzari Giovanni , Attili Fabia , Gabriella Brizi Maria , Rufini Vittoria , De Marinis Laura , Pontecorvi Alfredo , Rindi Guido , Bianchi Antonio

Medullary thyroid carcinoma (MTC) accounts for 1%–2% of thyroid cancers and has a variable clinical course. MTCs present with locoregional metastasis in 50% of patients and distant metastasis in 10% to 15% at the time of initial diagnosis. The lungs, liver, and bone are common metastatic sites, and distant metastasis is known to be a poor prognostic factor for long-term oncologic outcomes. We present the long course case, under somatostatin analogues (SSA) therapy, of a 7...

ea0063gp59 | Acromegaly and GH | ECE2019

Effects of pegvisomant and pasireotide LAR on incidence of vertebral fractures in patients with acromegaly resistant to treatment with first-line somatostatin analogs

Chiloiro Sabrina , Giampietro Antonella , Bianchi Antonio , Bima Chiara , Frara Stefano , Mirra Federica , Donfrancesco Federico , Fleseriu Cara Maria , Fleseriu Maria , Giustina Andrea , Laura De Marinis , Pontecorvi Alfredo

Purpose: Osteopathy is an emerging complication of acromegaly characterized by increased bone turnover, deterioration in bone microarchitecture and high risk of vertebral fractures (VFs). In somatostatin analog (SSA)-resistant patients (pts), Pegvisomant (PegV) and Pasireotide LAR (Pasi) are used for acromegaly treatment, but their effect on skeletal health is still not defined.Methods: In a longitudinal international multicenter study, we evaluated inci...

ea0049ep125 | Clinical case reports - Pituitary/Adrenal | ECE2017

Incidentaloma as a first manifestation of lymphoma

Diaz Pamela R. Chavez , Escola Cristina Alvarez , Larrauri Miriam Zapatero , Gomez Jose Tomas Castell , Bazan Alfredo Aguilera , de la Morena Lucrecia Herranz

Introduction: Incidentally discovered adrenal masses (incidentalomas) are common and in some cases differential diagnosis could be a challenge.Case report: A 55-years old woman presented with an incidental left adrenal mass of 36mm discovered on an abdominal ultrasound. As sole background she underwent resective surgery of an ovarian serous cyst. She denied symptoms like flushing, headache, diaphoresis or palpitations. Physical examination was irrelevant...

ea0049ep161 | Endocrine tumours and neoplasia | ECE2017

CYP2W1*6 polymorphism as a potential predictive marker of sensitivity to mitotane treatment in adrenocortical carcinoma.

Altieri Barbara , Herterich Sabine , Sbiera Silviu , Volante Marco , Kroiss Matthias , Casa Silvia Della , Pontecorvi Alfredo , Terzolo Massimo , Fassnacht Martin , Ronchi Cristina L.

Mitotane is the only approved drug for the treatment of advanced adrenocortical carcinoma (ACC) and we recently demonstrated that a high expression of cytochrome P450 2W1 (CYP2W1) correlated with response to mitotane. The association between CYP2W1 alleles and a generally increased cancer risk is under debate. Aim of the study was to evaluate the frequency of CYP2W1 polymorphisms and its correlation with the response to mitotane treatment in ACC patients.<p class="abstext"...

ea0049ep869 | Clinical case reports - Pituitary/Adrenal | ECE2017

Coexistence of thyrotropinoma and chronic autoimmune thyroiditis, a diagnostic challenge

Olaizola Izaskun , Egana Nerea , Bilbao Ismene , de Ciriza Maite Perez , Antunano Maria Luisa , Elias Estela , Garcia Cristina , Aranburu Maite , Yoldi Alfredo , Goena Miguel Maria

Introduction: TSHomas are rare TSH producing tumors, whereas chronic autoimmune thyroiditis is a frequent condition. Patients with TSHoma are characterized by increased circulating levels of peripheral thyroid hormones, but when a chronic autoimmune thyroiditis is associated, they may be normal or low, making the diagnosis challenging.Case report: A 55 year-old woman, with previous medical history of obesity and impaired fasting glucose, was diagnosed of...

ea0049ep997 | Pituitary - Clinical | ECE2017

Localization of the catheters during Bilateral sampling of the inferior petrosal sinuses can impact diagnostic power?

Chiloiro Sabrina , Pedicelli Alessandro , Valente Iacopo , Tartaglione Tommaso , Bianchi Antonio , Giampietro Antonella , Bima Chiara , Lauretti Liverana , Anile Carmelo , Pontecorvi Alfredo , De Marinis Laura

Introduction: Bilateral sampling of the inferior petrosal sinuses (IPSS) is considerate actually the best diagnostic test for Cushing.Patients and methods: We retrospectively reviewed our series of patients undergone IPSS for Cushing disease and we compared the difference between central and peripheral ACTH gradient in basal condition and after CRH stimulation in cases of localization of the tip of the catheters inside the inferior petrosal sinus or at t...

ea0049ep1260 | Thyroid (non-cancer) | ECE2017

Non-thyroidal illness syndrome in chronic renal failure and oxidative stress: preliminary data on triiodothyronine relationships with extracellular superoxide-dismutase

Mancini Antonio , Panocchia Nicola , Martino Giuseppe , Bruno Carmine , Silvestri Sonia , Orlando Patrick , Marcheggiani Fabio , Tazza Luigi , Tiano Luca , Gambaro Giovanni , Pontecorvi Alfredo

: Non-thyroidal-illness syndrome (NTIS) is present in chronic renal failure and considered an adaptive mechanism. However oxidative stress is linked to NTIS in a vicious circle, due to deiodinases alteration and negative effect on antioxidant levels or activity. One key antioxidant, protective toward ROS-mediated tissue damage, is extracellular superoxide-dismutase (ec-SOD), present in extracellular matrix and with a role in mediating nitric oxide-induced signaling. ec-SOD is ...